Catalyst Wire Dossier Catalyst Wire Dossier

Treprostinil (dry powder inhalation)

treprostinil · Liquidia Technologies, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Treprostinil (dry powder inhalation), covering 2024-07-30 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

See pricing